Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.
Published: April 3, 2019 at 02:00AM
from NYT Health https://ift.tt/2UfjXIc
Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.
Published: April 3, 2019 at 02:00AM
from NYT Health https://ift.tt/2UfjXIc